PharmaCielo Ltd.
PCLOF
$0.02
$0.00-3.31%
OTC PK
| 09/30/2025 | 06/30/2025 | 09/30/2024 | 09/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -10.31M | -10.31M | -11.22M |
| Total Depreciation and Amortization | -- | -- | 565.50K | 769.20K | 871.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 6.20M | 6.00M | 5.06M |
| Change in Net Operating Assets | -- | -- | 1.28M | 1.28M | 2.01M |
| Cash from Operations | -- | -- | -2.26M | -2.26M | -3.28M |
| Capital Expenditure | -- | -- | -3.90K | -3.90K | -2.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 74.60K | 74.60K | 159.40K |
| Cash from Investing | -- | -- | 70.70K | 70.70K | 157.20K |
| Total Debt Issued | -- | -- | 2.99M | 3.60M | 4.48M |
| Total Debt Repaid | -- | -- | -856.40K | -856.40K | -801.20K |
| Issuance of Common Stock | -- | -- | 607.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 237.00K | 237.00K | 237.00K |
| Cash from Financing | -- | -- | 2.19M | 2.19M | 2.90M |
| Foreign Exchange rate Adjustments | -- | -- | 7.50K | 7.40K | 7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 2.20K | 2.20K | -212.20K |